Legacy Citation Support

21 U.S.C. § 356-1

This citation is not available as a current section page in the published edition on this site, but the citation remains a meaningful historical or legacy reference.

Use the current title page and nearby sections below to continue browsing Title 21. When old citations remain in crawlers, briefs, or legacy links, this page preserves the citation locally instead of sending users to a dead end.

Browse Title 21 Search this title

Requested citation: 21 U.S.C. § 356-1
Current title: Title 21 — FOOD and Drugs
Search this title: /search?q=356-1&title=21

Nearby current sections

§ 355h — Regulation of certain nonprescription drugs that are marketed without an approved drug application
§ 355–1 — Risk evaluation and mitigation strategies
§ 355–2 — Actions for delays of generic drugs and biosimilar biological products
§ 356 — Expedited approval of drugs for serious or life-threatening diseases or conditions
§ 356a — Manufacturing changes
§ 356b — Reports of postmarketing studies
§ 356c — Discontinuance or interruption in the production of life-saving drugs
§ 356c–1 — Annual reporting on drug shortages